Publications by authors named "Y Imakura"

Article Synopsis
  • The small intestine is vital for absorbing drugs and nutrients but is also a target for drug toxicity and interactions with foods and bacteria.
  • Current models used to study the small intestine, like Caco-2 cells and animals, have limitations in accurately mimicking human metabolic processes.
  • The study explores human induced pluripotent stem cell-derived small intestinal epithelial cells (hiSIECs), finding they replicate key characteristics of human cells and can effectively assess drug toxicity, immune responses, and pharmacokinetics.
View Article and Find Full Text PDF

This study explores brain-network differences between the intrinsic and extrinsic motor coordinate frames. A connectivity model showing the coordinate frames difference was obtained using brain fMRI data of right wrist isometric flexions and extensions movements, performed in two forearm postures. The connectivity model was calculated by machine-learning-based neural representation and effective functional connectivity using psychophysiological interaction and dynamic causal modeling analyses.

View Article and Find Full Text PDF

Microphysiological systems (MPSs), including organ-on-a-chip (OoC), have attracted attention as a novel method for estimating the effects and side effects of drugs in drug discovery. To reproduce the dynamic in vivo environment, previous MPSs were connected to pump systems to perfuse culture medium. Therefore, most MPSs are not user-friendly and have poor throughput.

View Article and Find Full Text PDF

The endoderm, differentiated from human induced pluripotent stem cells (iPSCs), can differentiate into the small intestine and liver, which are vital for drug absorption and metabolism. The development of human iPSC-derived enterocytes (HiEnts) and hepatocytes (HiHeps) has been reported. However, pharmacokinetic function-deficiency of these cells remains to be elucidated.

View Article and Find Full Text PDF

To develop a novel intestinal drug absorption system using intestinal epithelial cells derived from human induced pluripotent stem (iPS) cells, the cells must possess sufficient pharmacokinetic functions. However, the CYP3A4/5 activities of human iPS cell-derived small intestinal epithelial cells prepared using conventional differentiation methods is low. Further, studies of the CYP3A4/5 activities of human iPS-derived and primary small intestinal cells are not available.

View Article and Find Full Text PDF